Endo Int'l (ENDP) to Acquire Auxilium (AUXL) in $2.6B Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Cantor Fitzgerald Upgrades Endo Health (ENDP) to Hold
October 13, 2014 7:36 AM EDTCantor Fitzgerald upgraded Endo Health (NASDAQ: ENDP) from Sell to Hold.
Analyst Irina Rivkind Koffler said, "Though we take a conservative view of Auxilium's portfolio, we believe that Endo can attain +6.7% EPS accretion in 2015, with longer-term increases in EBITDA to facilitate... More
MKM Partners Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
October 10, 2014 7:04 AM EDTMKM Partners downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.
For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $32.44 yesterday.
... MorePiper Jaffray Upgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Overweight
October 10, 2014 6:48 AM EDTPiper Jaffray upgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Neutral to Overweight with a price target of $84.00 (from $70.00) following the deal to acquire Auxilium (NASDAQ: AUXL).
Analyst David Amsellem commented, "We believe that the addition of AUXL... More
Mizuho Securities Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
October 10, 2014 6:35 AM EDTMizuho Securities downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.
For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $32.44 yesterday.
... MoreQLT, Inc. (QLTI) Reports Termination of Proposed Auxillium (AUXL) Merger
October 9, 2014 6:48 AM EDTQLT, Inc. (NASDAQ: QLTI) has been advised by Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) that Auxilium's board of directors has reviewed an offer from Endo International plc (Nasdaq: ENDP) to acquire all of the... More
QLT, Inc. (QLTI) on Watch Following Endo, Auxillium Deal
October 9, 2014 6:38 AM EDTQLT, Inc. (Nasdaq: QLTI) on watch following news that End International (Nasdaq: ENDP) is moving to acquire Auxilium Pharmaceuticals (Nasdaq: AUXL) for about $2.6 billion.
... More